Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genital Neoplasms, Female | 3 | 2021 | 108 | 1.990 |
Why?
|
| Hysterectomy | 4 | 2024 | 156 | 1.590 |
Why?
|
| Analgesia, Epidural | 2 | 2020 | 38 | 1.400 |
Why?
|
| Endometrial Neoplasms | 2 | 2022 | 208 | 1.300 |
Why?
|
| Ovarian Neoplasms | 3 | 2022 | 771 | 1.270 |
Why?
|
| Oncologists | 2 | 2024 | 37 | 0.800 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2022 | 61 | 0.800 |
Why?
|
| Drug Costs | 1 | 2021 | 63 | 0.720 |
Why?
|
| Cost-Benefit Analysis | 2 | 2021 | 465 | 0.710 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2022 | 333 | 0.640 |
Why?
|
| Telemedicine | 1 | 2021 | 192 | 0.610 |
Why?
|
| Postoperative Hemorrhage | 1 | 2018 | 46 | 0.610 |
Why?
|
| Erythrocyte Transfusion | 1 | 2018 | 73 | 0.590 |
Why?
|
| Kidney Neoplasms | 1 | 2022 | 523 | 0.580 |
Why?
|
| Cytoreduction Surgical Procedures | 1 | 2017 | 79 | 0.560 |
Why?
|
| Postoperative Complications | 3 | 2020 | 2299 | 0.490 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 1350 | 0.480 |
Why?
|
| Neoadjuvant Therapy | 1 | 2017 | 376 | 0.450 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 209 | 0.390 |
Why?
|
| Robotic Surgical Procedures | 1 | 2017 | 317 | 0.380 |
Why?
|
| Diabetes Mellitus | 2 | 2018 | 744 | 0.370 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 2505 | 0.370 |
Why?
|
| Female | 10 | 2024 | 46494 | 0.270 |
Why?
|
| Databases, Factual | 2 | 2020 | 860 | 0.250 |
Why?
|
| United States | 4 | 2024 | 7083 | 0.240 |
Why?
|
| Humans | 12 | 2024 | 89785 | 0.220 |
Why?
|
| Geography | 2 | 2021 | 227 | 0.220 |
Why?
|
| Lymph Node Excision | 1 | 2024 | 220 | 0.210 |
Why?
|
| Fallopian Tubes | 1 | 2022 | 42 | 0.210 |
Why?
|
| Rural Health Services | 1 | 2021 | 17 | 0.190 |
Why?
|
| Ovary | 1 | 2022 | 262 | 0.190 |
Why?
|
| Decision Trees | 1 | 2021 | 59 | 0.190 |
Why?
|
| Microsatellite Instability | 1 | 2021 | 53 | 0.190 |
Why?
|
| Markov Chains | 1 | 2021 | 127 | 0.180 |
Why?
|
| Phenylurea Compounds | 1 | 2021 | 95 | 0.180 |
Why?
|
| Quinolines | 1 | 2021 | 86 | 0.180 |
Why?
|
| Rural Population | 1 | 2021 | 147 | 0.180 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2021 | 144 | 0.180 |
Why?
|
| Retrospective Studies | 3 | 2020 | 9159 | 0.180 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2020 | 37 | 0.180 |
Why?
|
| Uterine Neoplasms | 1 | 2024 | 250 | 0.170 |
Why?
|
| Carboplatin | 1 | 2021 | 312 | 0.170 |
Why?
|
| Urinary Tract Infections | 1 | 2020 | 76 | 0.170 |
Why?
|
| Aged | 5 | 2024 | 19212 | 0.170 |
Why?
|
| Propensity Score | 1 | 2020 | 149 | 0.170 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 431 | 0.170 |
Why?
|
| Anesthesia, General | 1 | 2020 | 116 | 0.160 |
Why?
|
| Paclitaxel | 1 | 2021 | 474 | 0.160 |
Why?
|
| Blood Transfusion | 1 | 2020 | 171 | 0.160 |
Why?
|
| Pneumonia | 1 | 2020 | 183 | 0.160 |
Why?
|
| Preoperative Period | 1 | 2018 | 94 | 0.150 |
Why?
|
| Surgical Wound Infection | 1 | 2020 | 201 | 0.150 |
Why?
|
| Food Supply | 1 | 2018 | 29 | 0.150 |
Why?
|
| Middle Aged | 5 | 2024 | 26080 | 0.150 |
Why?
|
| Pulmonary Embolism | 1 | 2020 | 229 | 0.140 |
Why?
|
| Venous Thrombosis | 1 | 2020 | 255 | 0.140 |
Why?
|
| Incidence | 1 | 2021 | 1598 | 0.140 |
Why?
|
| Operative Time | 1 | 2017 | 145 | 0.140 |
Why?
|
| Length of Stay | 1 | 2020 | 744 | 0.140 |
Why?
|
| Quality Improvement | 1 | 2020 | 457 | 0.140 |
Why?
|
| Prospective Studies | 2 | 2022 | 4320 | 0.130 |
Why?
|
| Patient Readmission | 1 | 2020 | 354 | 0.130 |
Why?
|
| Neoplasm Staging | 1 | 2021 | 2000 | 0.130 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 952 | 0.120 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 850 | 0.120 |
Why?
|
| Blood Glucose | 1 | 2018 | 837 | 0.110 |
Why?
|
| Age Factors | 1 | 2018 | 1879 | 0.110 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 1729 | 0.110 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 2013 | 77 | 0.100 |
Why?
|
| Quality of Life | 1 | 2021 | 1674 | 0.100 |
Why?
|
| Calcium Signaling | 1 | 2013 | 138 | 0.100 |
Why?
|
| Cohort Studies | 1 | 2018 | 2886 | 0.100 |
Why?
|
| Patient Care Team | 1 | 2014 | 284 | 0.090 |
Why?
|
| Mutation | 1 | 2022 | 4164 | 0.090 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 364 | 0.090 |
Why?
|
| Caenorhabditis elegans | 1 | 2013 | 231 | 0.090 |
Why?
|
| Electronic Health Records | 1 | 2014 | 351 | 0.090 |
Why?
|
| Calcium | 1 | 2013 | 1179 | 0.070 |
Why?
|
| Risk Factors | 1 | 2018 | 5539 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 6778 | 0.070 |
Why?
|
| Adult | 3 | 2024 | 26767 | 0.060 |
Why?
|
| Kentucky | 1 | 2024 | 19 | 0.060 |
Why?
|
| Maryland | 1 | 2024 | 44 | 0.060 |
Why?
|
| North Carolina | 1 | 2024 | 51 | 0.060 |
Why?
|
| Florida | 1 | 2024 | 60 | 0.060 |
Why?
|
| Travel | 1 | 2024 | 72 | 0.060 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2024 | 258 | 0.050 |
Why?
|
| Postmenopause | 1 | 2022 | 102 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2022 | 156 | 0.050 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 435 | 0.040 |
Why?
|
| Chromatin | 1 | 2022 | 403 | 0.040 |
Why?
|
| RNA | 1 | 2022 | 583 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2018 | 153 | 0.040 |
Why?
|
| Nutrition Surveys | 1 | 2018 | 111 | 0.040 |
Why?
|
| Food | 1 | 2018 | 89 | 0.040 |
Why?
|
| Feeding Behavior | 1 | 2018 | 328 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 1083 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2013 | 117 | 0.030 |
Why?
|
| Calmodulin | 1 | 2013 | 50 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2013 | 203 | 0.030 |
Why?
|
| Protons | 1 | 2013 | 101 | 0.030 |
Why?
|
| Biosensing Techniques | 1 | 2013 | 73 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 414 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2013 | 503 | 0.020 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2013 | 113 | 0.020 |
Why?
|
| Models, Biological | 1 | 2013 | 1765 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2013 | 3402 | 0.010 |
Why?
|
| Male | 1 | 2018 | 42582 | 0.010 |
Why?
|
| Animals | 1 | 2013 | 27512 | 0.010 |
Why?
|